Vitamin Shoppe (VSI) Misses Q2 EPS by 16c, Miss on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Nasdaq ends higher as AI heavyweights rebound ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- Broadcom shares climb as AI chip financing deal supports rally
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
Vitamin Shoppe (VSI) PT Lowered to $6 at Barclays
August 10, 2017 9:10 AM EDTBarclays lowered its price target on Vitamin Shoppe (NYSE: VSI) to $6.00 (from $13.00) while maintaining a Equalweight rating.
... MoreVitamin Shoppe (VSI) PT Lowered to $6 at Goldman Sachs
August 10, 2017 6:47 AM EDTGoldman Sachs lowered its price target on Vitamin Shoppe (NYSE: VSI) to $6.00 (from $13.00) while maintaining a Sell rating.
Analyst Stephen Tanal expects competitive pressure to persist. The analyst reminds clients that mass merchants, grocers, drug stores and online retail shave all been... More



